Hodgkin Lymphoma Drug Improves Remission Rate by 87 Percent

December 7, 2014 3:41 PM

3 0

Researchers at Dana-Farber Cancer Institute have successfully developed a new therapy that improves the remission rate of patients with Hodgkin lymphoma by 87 percent. Their findings provide new evidence that treatments aimed at boosting the body's immune system can be used to kill cancer cells.

Researchers at Dana-Farber Cancer Institute have successfully developed a new therapy that improves the remission rate of patients with Hodgkin lymphoma by 87 percent. Their findings provide new evidence that treatments aimed at boosting the body's immune system can be used to kill cancer cells.

Read more

To category page

Loading...